Roger Colobrán

12.7k total citations
67 papers, 1.0k citations indexed

About

Roger Colobrán is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Roger Colobrán has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 20 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Roger Colobrán's work include Immunodeficiency and Autoimmune Disorders (22 papers), T-cell and B-cell Immunology (13 papers) and Diabetes and associated disorders (10 papers). Roger Colobrán is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (22 papers), T-cell and B-cell Immunology (13 papers) and Diabetes and associated disorders (10 papers). Roger Colobrán collaborates with scholars based in Spain, United States and Australia. Roger Colobrán's co-authors include Ricardo Pujol‐Borrell, Manel Juan, Ana Marín, Mireia Giménez‐Barcons, Pere Soler‐Palacín, Mónica Martínez‐Gallo, Clara Franco‐Jarava, Anna Casteràs, Rosa Faner and Marina García-Prat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Roger Colobrán

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Colobrán Spain 20 552 281 231 176 167 67 1.0k
Mehran Ghaderi Sweden 23 471 0.9× 300 1.1× 319 1.4× 201 1.1× 219 1.3× 57 1.4k
Yannick Simoni Singapore 16 822 1.5× 296 1.1× 275 1.2× 92 0.5× 250 1.5× 28 1.2k
Patrizia Mella Italy 18 553 1.0× 258 0.9× 238 1.0× 105 0.6× 281 1.7× 29 1.2k
Federica Barzaghi Italy 13 741 1.3× 347 1.2× 132 0.6× 81 0.5× 171 1.0× 27 1.0k
Daniel Rodríguez‐Pinto United States 11 519 0.9× 279 1.0× 208 0.9× 150 0.9× 117 0.7× 12 988
Maria Bettini United States 18 885 1.6× 396 1.4× 165 0.7× 128 0.7× 339 2.0× 40 1.3k
Anthony K. Shum United States 15 525 1.0× 133 0.5× 304 1.3× 134 0.8× 52 0.3× 27 955
Chun Jing Wang United Kingdom 14 891 1.6× 303 1.1× 96 0.4× 91 0.5× 256 1.5× 20 1.1k
Daniel B. Rainbow United Kingdom 20 606 1.1× 441 1.6× 219 0.9× 110 0.6× 233 1.4× 35 1.3k
Per Marits Sweden 19 663 1.2× 164 0.6× 236 1.0× 47 0.3× 358 2.1× 37 1.1k

Countries citing papers authored by Roger Colobrán

Since Specialization
Citations

This map shows the geographic impact of Roger Colobrán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Colobrán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Colobrán more than expected).

Fields of papers citing papers by Roger Colobrán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Colobrán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Colobrán. The network helps show where Roger Colobrán may publish in the future.

Co-authorship network of co-authors of Roger Colobrán

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Colobrán. A scholar is included among the top collaborators of Roger Colobrán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Colobrán. Roger Colobrán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larrosa-García, María, Irene Agraz Pamplona, Mónica Martínez‐Gallo, et al.. (2025). Pharmacokinetic Characterization of Rituximab in Patients with Glomerular Diseases. Therapeutic Drug Monitoring. 47(6). e142–e149.
2.
Aguiló‐Cucurull, Aina, et al.. (2025). De Novo or inherited: gonosomal mosaicism in hereditary angioedema due to C1 inhibitor deficiency. Frontiers in Immunology. 16. 1550380–1550380. 1 indexed citations
3.
García-Prat, Marina, Alba Parra-Martínez, Clara Franco‐Jarava, et al.. (2024). Role of Skewed X-Chromosome Inactivation in Common Variable Immunodeficiency. Journal of Clinical Immunology. 44(2). 54–54. 1 indexed citations
4.
García-Prat, Marina, Alba Parra-Martínez, Aina Aguiló‐Cucurull, et al.. (2024). Heterozygous Predicted Loss-of-function Variants of TRAF3 in Patients with Common Variable Immunodeficiency. Journal of Clinical Immunology. 45(1). 47–47. 1 indexed citations
5.
Andrés‐León, Eduardo, Javier Martı́n, Albert Selva-O’Callaghan, et al.. (2024). Expanding the landscape of systemic sclerosis-related autoantibodies through RNA immunoprecipitation coupled with massive parallel sequencing. Journal of Autoimmunity. 149. 103328–103328.
7.
Selva-O’Callaghan, Albert, et al.. (2023). Anti-nuclear valosin-containing protein-like autoantibody is associated with calcinosis and higher risk of cancer in systemic sclerosis. Lara D. Veeken. 63(8). 2278–2283. 7 indexed citations
8.
Rivière, Jacques G., Clara Franco‐Jarava, Andrea Martín‐Nalda, et al.. (2023). Molecular Challenges in the Diagnosis of X-Linked Chronic Granulomatous Disease: CNVs, Intronic Variants, Skewed X-Chromosome Inactivation, and Gonosomal Mosaicism. Journal of Clinical Immunology. 43(8). 1953–1963. 5 indexed citations
9.
Zhang, Peng, Quentin Philippot, Weicheng Ren, et al.. (2022). Genome-wide detection of human variants that disrupt intronic branchpoints. Proceedings of the National Academy of Sciences. 119(44). e2211194119–e2211194119. 23 indexed citations
10.
Martín-Nalda, Andrea, Mónica Martínez‐Gallo, Marina García-Prat, et al.. (2021). Newborn Screening for SCID: Experience in Spain (Catalonia). International Journal of Neonatal Screening. 7(3). 46–46. 11 indexed citations
11.
Chen, Jie, Huie Jing, Andrea Martín-Nalda, et al.. (2021). Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis. The Journal of Experimental Medicine. 218(12). 20 indexed citations
12.
Martín-Nalda, Andrea, Jacques G. Rivière, Marina García-Prat, et al.. (2021). Early Diagnosis and Treatment of Purine Nucleoside Phosphorylase (PNP) Deficiency through TREC-Based Newborn Screening. International Journal of Neonatal Screening. 7(4). 62–62. 5 indexed citations
13.
García-Prat, Marina, Andrea Martín-Nalda, Oliver Drechsel, et al.. (2019). The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype. Clinical & Experimental Immunology. 200(1). 61–72. 4 indexed citations
14.
Dieli-Crimi, Romina, Mónica Martínez‐Gallo, Clara Franco‐Jarava, et al.. (2018). Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations. Clinical Immunology. 195. 49–58. 25 indexed citations
15.
Franco‐Jarava, Clara, Xavier Solanich, Francisco Morandeira, et al.. (2017). Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations. Journal of Clinical Immunology. 37(8). 781–789. 11 indexed citations
16.
Franco‐Jarava, Clara, David Comas, Ann Orren, M. Hernández, & Roger Colobrán. (2017). Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease. Clinical & Experimental Immunology. 189(2). 226–231. 5 indexed citations
17.
Álvarez, Iñaki, Javier Collado, Roger Colobrán, et al.. (2015). Central T cell tolerance: Identification of tissue-restricted autoantigens in the thymus HLA-DR peptidome. Journal of Autoimmunity. 60. 12–19. 24 indexed citations
18.
Colobrán, Roger, Rosa Faner, Lars‐Oliver Tykocinski, et al.. (2011). Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance. Human Molecular Genetics. 20(17). 3415–3423. 61 indexed citations
19.
Carretero-Iglesia, Laura, Aram Boada, Roger Colobrán, et al.. (2011). CCL4L Polymorphisms and CCL4/CCL4L Serum Levels Are Associated with Psoriasis Severity. Journal of Investigative Dermatology. 131(9). 1830–1837. 28 indexed citations
20.
Colobrán, Roger, Yaqoub Ashhab, Anuska Llano, et al.. (2005). Multiple Products Derived from Two CCL4 Loci: High Incidence of a New Polymorphism in HIV+ Patients. The Journal of Immunology. 174(9). 5655–5664. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026